Refining the role of antiplatelet therapy for atrial fibrillation Jai SinghDeepak L. Bhatt Clinical Trials Report 01 July 2009 Pages: 239 - 240
Cardioverter-defibrillators for primary and secondary prevention in adults with tetralogy of Fallot Elyse Foster Clinical Trials Report 01 July 2009 Pages: 241 - 242
Advances in percutaneous coronary intervention Somjot S. BrarGregg W. Stone OriginalPaper 01 July 2009 Pages: 245 - 251
New noninvasive imaging technologies in coronary artery disease Juan GaztanagaMario J. Garcia OriginalPaper 01 July 2009 Pages: 252 - 257
Cardiovascular disease and type 2 diabetes mellitus: Regulating glucose and regulating drugs M. Odette GoreDarren K. McGuire OriginalPaper 01 July 2009 Pages: 258 - 263
Medical therapy in acute coronary syndromes: Which medicines and at what doses? Dmitriy KireyevEdward C. YunWilliam E. Boden OriginalPaper 01 July 2009 Pages: 267 - 275
Lipid reduction in acute coronary syndrome: How much, when, and how? Miriam JacobLeslie Cho OriginalPaper 01 July 2009 Pages: 276 - 281
Genomic view of factors leading to plaque instability Sonny DandonaRobert Roberts OriginalPaper 01 July 2009 Pages: 282 - 287
Transition and transfer from pediatric to adult care of young adults with complex congenital heart disease Alison Knauth MeadowsValerie BoscoArwa Saidi OriginalPaper 01 July 2009 Pages: 291 - 297
Choosing the best contraceptive method for the adult with congenital heart disease Candice K. SilversidesMathew SermerSamuel C. Siu OriginalPaper 01 July 2009 Pages: 298 - 305
Percutaneous interventions in adults with congenital heart disease: Expanding indications and opportunities Stéphane NobleRéda Ibrahim OriginalPaper 01 July 2009 Pages: 306 - 313
Pulmonary hypertension complicating congenital heart disease J. Eduardo Rame OriginalPaper 01 July 2009 Pages: 314 - 320